BPC-157 (Body Protection Compound) Research

6 peer-reviewed studies supporting this intervention. Evidence rating: B

6 Studies
0 RCTs
0 Meta-analyses
2010-2025 Year Range

Study Comparison

Study Year Type Journal Key Finding
Vasireddi N et al. 2025 Systematic Review HSS journal : the musculoskeletal journal of Hospital for Special Surgery Systematic review of 32 preclinical studies finds BPC-157 consistently accelerates healing of tendons, ligaments, muscles, and bones in orthopaedic sports medicine models.
Seiwerth S et al. 2021 Review Frontiers in pharmacology Comprehensive review demonstrates BPC-157 accelerates wound healing across multiple tissue types including skin burns, diabetic wounds, fistulas, and bone fractures in animal models.
Predrag Sikiric et al. 2019 Study Current Pharmaceutical Design BPC-157 demonstrates healing effects across multiple tissue types including gut, tendon, muscle, and nerve through growth factor modulation
Gwyer D et al. 2019 Review Cell and tissue research Review of BPC-157's musculoskeletal healing mechanisms shows it accelerates tendon, ligament, and muscle repair through angiogenesis promotion, inflammation modulation, and growth factor upregulation.
Chang CH et al. 2015 Study Molecules BPC-157 upregulates growth hormone receptors and accelerates tendon healing through enhanced fibroblast activity
Danijela Pevec et al. 2010 Study Medical Science Monitor BPC-157 counteracts corticosteroid-impaired healing and accelerates Achilles tendon and muscle recovery

Study Details

Vasireddi N, Hahamyan H, Salata MJ, et al.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Key Finding: Systematic review of 32 preclinical studies finds BPC-157 consistently accelerates healing of tendons, ligaments, muscles, and bones in orthopaedic sports medicine models.
View Summary

This systematic review evaluated the emerging use of BPC-157 in orthopaedic sports medicine by analyzing 32 preclinical studies. The review assessed BPC-157's effects across multiple musculoskeletal tissue types including tendons, ligaments, muscles, and bones.

Across the included studies, BPC-157 demonstrated consistent benefits for tissue healing, including accelerated tendon-to-bone integration, improved ligament repair, enhanced muscle regeneration after injury, and promotion of bone fracture healing. The peptide appears to work through multiple pathways including upregulation of growth factors, promotion of angiogenesis, and modulation of nitric oxide signaling.

While the preclinical evidence is encouraging, the authors note that all included studies were animal models. The review highlights a significant gap in human clinical trial data and calls for well-designed randomized controlled trials to validate these findings in human patients before BPC-157 can be recommended for clinical orthopaedic use.

Seiwerth S, Milavic M, Vukojevic J, et al.

Frontiers in pharmacology

Key Finding: Comprehensive review demonstrates BPC-157 accelerates wound healing across multiple tissue types including skin burns, diabetic wounds, fistulas, and bone fractures in animal models.
View Summary

This comprehensive review examines the wound healing properties of BPC-157 (stable gastric pentadecapeptide) across a wide range of tissue injury models. The authors, from the University of Zagreb where much of the foundational BPC-157 research has been conducted, synthesize evidence from numerous preclinical studies.

BPC-157 demonstrated significant wound healing effects in burn skin lesions, excisional wounds in diabetic rats, tracheocutaneous fistulas, perforated cecum defects, and tibial fractures. The peptide promoted angiogenesis, accelerated granulation tissue formation, and enhanced collagen organization. Notably, BPC-157 showed efficacy even in compromised healing scenarios such as diabetic wound models, where healing is typically impaired.

The review highlights BPC-157's interaction with the nitric oxide system, growth factor pathways, and its ability to counteract tissue damage from corticosteroids and NSAIDs. The authors propose that BPC-157 acts as a mediator of Robert's cytoprotection, extending protective and healing effects beyond the gastrointestinal tract to virtually all organ systems. While the breadth of evidence is impressive, the review acknowledges that human clinical trials remain limited.

Predrag Sikiric, Marko Seiwerth, Domagoj Drmic, et al.

Current Pharmaceutical Design

Key Finding: BPC-157 demonstrates healing effects across multiple tissue types including gut, tendon, muscle, and nerve through growth factor modulation
View Summary

Comprehensive review of BPC-157 research spanning decades of studies. The gastric pentadecapeptide shows consistent healing effects across gastrointestinal tract, musculoskeletal system, and nervous system in animal models.

Gwyer D, Wragg NM, Wilson SL

Cell and tissue research

Key Finding: Review of BPC-157's musculoskeletal healing mechanisms shows it accelerates tendon, ligament, and muscle repair through angiogenesis promotion, inflammation modulation, and growth factor upregulation.
View Summary

This review examines the role of BPC-157 in accelerating musculoskeletal soft tissue healing, focusing on tendons, ligaments, and muscles. The authors consolidate findings from preclinical studies to characterize BPC-157's mechanisms of action and therapeutic potential for sports and orthopedic injuries.

BPC-157 was shown to promote healing through several key pathways: stimulation of angiogenesis via increased VEGF expression, modulation of inflammatory responses, upregulation of growth hormone receptors in injured tissue, and activation of the FAK-paxillin signaling pathway critical for tendon and ligament repair. The peptide also demonstrated the ability to counteract the negative effects of corticosteroids and NSAIDs on tissue healing.

The review highlights BPC-157's unique stability in gastric juice (unlike most peptides) and its efficacy across multiple administration routes including subcutaneous injection and oral delivery. While the authors conclude that BPC-157 shows strong promise for musculoskeletal soft tissue repair, they emphasize the need for human clinical trials to translate these preclinical findings into evidence-based clinical practice.

Chang CH, Tsai WC, Hsu YH, Pang JH

Molecules

Key Finding: BPC-157 upregulates growth hormone receptors and accelerates tendon healing through enhanced fibroblast activity
View Summary

Study examining BPC-157's effects on tendon fibroblast cells and growth hormone receptor expression. Results suggest BPC-157 accelerates tendon-to-bone healing by enhancing cellular response to growth factors.

Danijela Pevec, Bozidar Novinscak, Lovre Brcic, et al.

Medical Science Monitor

Key Finding: BPC-157 counteracts corticosteroid-impaired healing and accelerates Achilles tendon and muscle recovery
View Summary

Study investigating whether BPC-157 can overcome corticosteroid-induced impairment of healing. Particularly relevant for athletes and patients who have received steroid injections.

Evidence Assessment

B Moderate Evidence

This intervention has moderate evidence from some randomized trials and consistent observational data, though more research would strengthen conclusions.